Cell-free DNA: a metabolic byproduct with diagnostic and prognostic potential in rheumatic disorders
The release of intracellular DNA into the extracellular area occurs via two pathways: cell death and active secretion by cells. The DNA, which is free in the extracellular space, is commonly known as Cell-Free DNA (cfDNA). In healthy people, the levels of cfDNA in the circulation are notably minimal...
Saved in:
Main Authors: | Fancheng Liu, Yazhen Su, Xinling Liu, Li Zhao, Zewen Wu, Yang Liu, Liyun Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-02-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1537934/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
South African Rheumatism and Arthritis Association 2024 updated guidelines for the management of rheumatoid arthritis
by: G Tarr, et al.
Published: (2024-09-01) -
Primer on the Rheumatic Diseases /
Published: (1993) -
Enhancement of CD8+T cell cytotoxicity activity by IFN-α implies alternative pathologic role in systemic lupus erythematosus
by: Chen-xing Zhang, et al.
Published: (2025-06-01) -
Controversy About Management of Osteoarthritis with Disease-modifying Anti-rheumatic Drugs
by: CUI Hanshu, et al.
Published: (2025-01-01) -
COVID-19 or systemic lupus erythematosus: Attention to similarity
by: Erden Abdulsamet, et al.
Published: (2025-01-01)